The Scientific Edge in Pharmaceutical IP Litigation
609.285.8344
info@acumenbiopharma.com
The Scientific Edge in Pharmaceutical IP Litigation
Toggle navigation
Services
Areas of Expertise
Our Process
Case Studies
About Us
Executive Team
Meet the Antitrust & Product Launch Experts
Client List
Contact Us
SITEMAP
#1714 (no title)
Abuse-Deterrent Formulations and Technologies
Acumen Technical Notes-Sample
Antitrust Litigation
Are branded and generic versions of the same medication the same?
Are you infringing someone’s patent? Or is someone infringing yours?
Blog
Client List
Disclaimer
Executive Team
Home
Materials and products are tested during process development, during commercial manufacturing…and during litigation.
Meet the Antitrust & Product Launch Experts
PIV Product Launch Strategies
Privacy
Process – Establish the Relationship
Process – Initial Assessment
Process – Introduce Experts
Process – Laboratory Testing
Process – Ongoing Communication
Sitemap
Terms
Areas of Expertise
Services
Our Process
Case Studies
About Us
Contact Us
Category:
case studies
Category:
Expertise
Category:
General
Category:
News
Daisy Rivera-Muzzio served as moderator for the three-part LES Pharma Webinar Series: IP Litigation in the Pharma Industry.
Dr. Fernando Muzzio provides testimony on advanced pharmaceutical manufacturing and on drug shortages in front of the Health Subcommittee of the US House of Representatives on January 26, 2020
Dr. Muzzio and C-SOPS received Chairman award from the Research and development council of New Jersey
Dr. Fernando J. Muzzio, opinion contributor in THE HILL
Dr. Fernando J. Muzzio is a recipient of the Inventor of the Year Award from the New Jersey Inventors Hall of Fame
Acumen BioPharma Launches New Business Unit, Expands Capabilities into Continuous Pharmaceutical Manufacturing
Category:
Patent Infringement
Category:
Uncategorized
Testimonial 3
Testimonial 2
Testimonial 1
Case Study 8 – Internal structure of a tablet
Case Study 7 – Comparative analysis of tablets with different coatings
Case Study 6 – Internal structure of tablets manufactured by alternative methods
Case Study 5 – Internal structure of tablets manufactured by direct compression and by hot melt extrusion
Case Study 4 – Abuse deterrent opioid products litigation, 2014
Case Study 3 – Abuse deterrent opioid products litigation, 2013 (same case as above)
Case Study 2 – Abuse deterrent opioid products litigation, 2013
Case Study 1 – The internal structure of a pharmaceutical product
Ingredients and Finished Product Testing for Quality Assurance and Regulatory Compliance
Abuse Deterrent Formulations and Technologies
Determination of Product Structure
Analysis of Patent Infringement
PIV Product Launch Strategies